The abstract is read at the publisher; the summary is JClub's.
Updated international consensus for Silver-Russell syndrome (SRS) establishes primarily molecular diagnostic criteria, emphasizing maternal upd(7)mat and 11p15 loss of methylation at H19/IGF2:IG-DMR to guide subgroup-specific care pathways.
- Why it matters: Prior guidance is outdated and SRS shows substantial clinical and genetic heterogeneity, creating a need for stricter diagnostic standards and coordinated management that reflects genomic and epigenomic advances.
- What they did: The statement was developed via a Delphi-like process using published evidence and expert opinion, and it recommends expert multidisciplinary care targeting growth failure, feeding problems, later weight gain, metabolic risks, and neurocognitive and psychosocial issues.
- The result: Molecular stratification is positioned to tailor lifelong management for SRS subgroups and related imprinting disorders, reflecting evidence of increased metabolic disease risk from adolescence into adulthood.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.